NASDAQ

Travere Therapeutics, Inc. (TVTX)

♥ 654 Thanks from members

Live price chart, market sentiment, and community perspectives for Travere Therapeutics, Inc. (NASDAQ: TVTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Geir AndresenFounder: J. Kevin BuchiLeadership: Eric Dube (CEO)Leadership: Peter Anastasiou (Chief Commercial Officer)Holder: BlackRockHolder: Vanguard GroupHolder: FMR LLCHolder: Baker Bros. AdvisorsFilspari (sparsentan)ChenodalCholbamPegzilarginase#TVTX#Travere Therapeutics#rare disease biopharma#nephrology drugs#Filspari